$IAM
Iambic Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
IAM chart
What traders are saying about $IAM
Latest postsIambic Therapeutics, Inc. news
- Iambic Therapeutics (IAM) Stock Forecast and Price Target 2026 $IAM
MarketBeat ·
- Top 5 More Healthcare Pre-Market Gainers on Tuesday: Tempest Therapeutics (NASDAQ:TPST) +12.06%, PMV Pharmaceuticals (NASDAQ:PMVP) +11.27%, Iambic Therapeutics (NASDAQ:IAM) +10.69%, Autonomix Medical (NASDAQ:AMIX) +10.00%, Autol
Kalkine ·
- Why Is Iambic Therapeutics (NASDAQ:IAM) Rising 10.69% Pre-Market on Tuesday?
Kalkine ·
- Iambic Therapeutics Jumps 17% After-Hours as Wall Street Turns Bullish on Its AI-Powered Drug Discovery Platform
Benzinga ·
- Citi Initiates Iambic Therapeutics(IAM.US) With Buy Rating, Announces Target Price $22
Moomoo ·
- Iambic Therapeutics wins Bank of America backing with 194% upside forecast
proactiveinvestors.com ·
- Qatar Investment Authority reports over 5% ownership in Iambic Therapeutics (IAM).
Stock Titan ·
- Iambic Therapeutics Initiated at Buy by B of A Securities
Moomoo ·
- JP Morgan initiates coverage of Iambic Therapeutics at Overweight, sets price target at $22
TradingView ·
- Citigroup initiates coverage of Iambic Therapeutics at Buy, sets price target at $22
TradingView ·
- Iambic to participate in Jefferies Global Healthcare Conference
Yahoo Finance ·
- AI could improve the odds of developing successful medicines, says Iambic's CEO, who will join a panel.
Stock Titan ·
Iambic Therapeutics, Inc. key financials
No XBRL financial data is available for this company yet.
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Iambic Therapeutics, Inc.
- Ticker
- IAM (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1997038
Frequently asked questions
What exchange is Iambic Therapeutics, Inc. listed on?
Iambic Therapeutics, Inc. trades on the Nasdaq under the ticker symbol IAM.
What industry is Iambic Therapeutics, Inc. in?
Iambic Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Iambic Therapeutics, Inc. headquartered?
Iambic Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Iambic Therapeutics, Inc.'s fiscal year end?
Iambic Therapeutics, Inc.'s fiscal year ends on December 31.